These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 12354209)

  • 1. Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics.
    Kuriyama T; Karasawa T; Nakagawa K; Nakamura S; Yamamoto E
    Oral Microbiol Immunol; 2002 Oct; 17(5):285-9. PubMed ID: 12354209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of beta-lactamase production and antimicrobial susceptibility of anaerobic gram-negative rods isolated from pus specimens of orofacial odontogenic infections.
    Kuriyama T; Karasawa T; Nakagawa K; Yamamoto E; Nakamura S
    Oral Microbiol Immunol; 2001 Feb; 16(1):10-5. PubMed ID: 11169133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections.
    Kuriyama T; Karasawa T; Nakagawa K; Saiki Y; Yamamoto E; Nakamura S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Nov; 90(5):600-8. PubMed ID: 11077383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Past administration of beta-lactam antibiotics and increase in the emergence of beta-lactamase-producing bacteria in patients with orofacial odontogenic infections.
    Kuriyama T; Nakagawa K; Karasawa T; Saiki Y; Yamamoto E; Nakamura S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Feb; 89(2):186-92. PubMed ID: 10673654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antimicrobial susceptibility for β-lactams against clinical isolates from 51 medical centers in Japan (2008).
    Ishii Y; Ueda C; Kouyama Y; Tateda K; Yamaguchi K
    Diagn Microbiol Infect Dis; 2011 Apr; 69(4):443-8. PubMed ID: 21396543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections.
    Kuriyama T; Karasawa T; Nakagawa K; Yamamoto E; Nakamura S
    Oral Microbiol Immunol; 2002 Apr; 17(2):132-5. PubMed ID: 11929563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
    Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
    J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of antimicrobial susceptibility for beta-lactams using the Etest method against clinical isolates from 100 medical centers in Japan (2006).
    Ishii Y; Tateda K; Yamaguchi K;
    Diagn Microbiol Infect Dis; 2008 Feb; 60(2):177-83. PubMed ID: 17931820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
    Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro activities of sulopenem, a new parenteral penem, against anaerobes].
    Watanabe K; Kato N; Tanaka-Bandoh K; Tanaka Y; Kato H; Ueno K
    Jpn J Antibiot; 1996 Apr; 49(4):367-76. PubMed ID: 8786627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of 800 anaerobic isolates from patients with dentoalveolar infection to 13 oral antibiotics.
    Kuriyama T; Williams DW; Yanagisawa M; Iwahara K; Shimizu C; Nakagawa K; Yamamoto E; Karasawa T
    Oral Microbiol Immunol; 2007 Aug; 22(4):285-8. PubMed ID: 17600542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
    Jones RN; Salazar JC; Pfaller MA; Doern GV
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):265-72. PubMed ID: 9458984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative clinical and epidemiological evaluation of beta-lactam antibiotics in the treatment of intraabdominal infections].
    Beketov AS; Sidorenko SV; Pisarev VV; Komarov RM
    Antibiot Khimioter; 2003; 48(3):34-41. PubMed ID: 12914120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone.
    Winston DJ; Ho WG; Bruckner DA; Champlin RE
    Ann Intern Med; 1991 Dec; 115(11):849-59. PubMed ID: 1952471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of antimicrobial activity of beta-lactam antibiotics by Etest against clinical isolates from 100 medical centers in Japan (2004).
    Ishii Y; Alba J; Kimura S; Yamaguchi K
    Diagn Microbiol Infect Dis; 2006 Jun; 55(2):143-8. PubMed ID: 16529905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiology and antibiotic sensitivities of head and neck space infections of odontogenic origin.
    Rega AJ; Aziz SR; Ziccardi VB
    J Oral Maxillofac Surg; 2006 Sep; 64(9):1377-80. PubMed ID: 16916672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species.
    Aldridge KE; Ashcraft D; Cambre K; Pierson CL; Jenkins SG; Rosenblatt JE
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1238-43. PubMed ID: 11257040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North America: 2001-2002).
    Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2003 Oct; 47(2):435-40. PubMed ID: 14522519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.
    Patankar M; Sukumaran S; Chhibba A; Nayak U; Sequeira L
    J Assoc Physicians India; 2012 Nov; 60():22-4. PubMed ID: 23767198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
    Neu HC
    Annu Rev Pharmacol Toxicol; 1982; 22():599-642. PubMed ID: 6282190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.